CLINICAL_TRIALS
trial_result
· 2013-01-31
Clinical Trial Update: Effects of Coenzyme Q10 (CoQ) in Parkinson Disease [Phase 3]
Summary
Phase 3 trial evaluating coenzyme Q10 in Parkinson disease has terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Weill Medical College of Cornell University | Conditions: Parkinson Disease | Phase 3 | Status: TERMINATED | Results posted: 2013-01-31